These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10632467

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N, Schlammadinger A, Vauterin S, Cooper S, Descheemaeker G, Tornai I, Deckmyn H.
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ, Agneskirchner J, Bode PA, Spannagl M, Wurzinger LJ.
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [Abstract] [Full Text] [Related]

  • 9. Investigation of the mechanisms of monoclonal antibody-induced platelet activation.
    Horsewood P, Hayward CP, Warkentin TE, Kelton JG.
    Blood; 1991 Aug 15; 78(4):1019-26. PubMed ID: 1714324
    [Abstract] [Full Text] [Related]

  • 10. Activating effects of GPIIb/IIIa blockers: an intrinsic consequence of ligand-mimetic properties.
    Peter K, Schwarz M, Bode C.
    Circulation; 2002 May 28; 105(21):E180-1. PubMed ID: 12034670
    [No Abstract] [Full Text] [Related]

  • 11. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM, Buckland RJ, Holgate CE, Storey RF.
    Platelets; 2005 Nov 28; 16(7):398-407. PubMed ID: 16236601
    [Abstract] [Full Text] [Related]

  • 12. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
    Arvieux J, Roussel B, Pouzol P, Colomb MG.
    Thromb Haemost; 1993 Aug 02; 70(2):336-41. PubMed ID: 8236145
    [Abstract] [Full Text] [Related]

  • 13. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG, Vyzova TV, Lukin VV, Tikhomirov OIu, Berndt M, Kouns W, Mazurov AV.
    Biokhimiia; 1996 Mar 02; 61(3):412-28. PubMed ID: 8724599
    [Abstract] [Full Text] [Related]

  • 14. Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists.
    Quinn M, Deering A, Stewart M, Cox D, Foley B, Fitzgerald D.
    Circulation; 1999 May 04; 99(17):2231-8. PubMed ID: 10226086
    [Abstract] [Full Text] [Related]

  • 15. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F, Rossi E, Pareti FI, Colli S, Tremoli E, Gallo L.
    Haematologica; 2001 Feb 04; 86(2):192-8. PubMed ID: 11224490
    [Abstract] [Full Text] [Related]

  • 16. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
    Mazurov AV, Pevzner DV, Khaspekova SG, Dudnik OA, Byzova TV, Vlasik TN, Bakharev VN, Pistsov MIu, Staroverov II, Ruda MIa.
    Ter Arkh; 2001 Feb 04; 73(9):66-73. PubMed ID: 11642086
    [Abstract] [Full Text] [Related]

  • 17. Topographical Association of the Platelet Fc-receptor with the Glycoprotein IIb-IIIa Complex.
    Berndt MC, Mazurov AV, Vinogradov DV, Burns GF, Chesterman CN.
    Platelets; 1993 Feb 04; 4(4):190-6. PubMed ID: 21043840
    [Abstract] [Full Text] [Related]

  • 18. Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent.
    De Reys S, Blom C, Lepoudre B, Declerck PJ, De Ley M, Vermylen J, Deckmyn H.
    Blood; 1993 Apr 01; 81(7):1792-800. PubMed ID: 8461465
    [Abstract] [Full Text] [Related]

  • 19. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ, Taatjes DJ, Sobel BE.
    Cardiovasc Res; 2000 Jan 14; 45(2):437-46. PubMed ID: 10728364
    [Abstract] [Full Text] [Related]

  • 20. Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.
    Untch B, Ahmad S, Messmore HL, Schultz CL, Ma Q, Hoppensteadt DA, Walenga JM, Fareed J.
    Thromb Res; 2002 Apr 15; 106(2):149-56. PubMed ID: 12182915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.